New England Journal of Medicine Publishes Positive Results of the Pivotal Trial of Cablivi (caplacizumab) for Rare Blood Clotting Disorder

New England Journal of Medicine Publishes Positive Results of the Pivotal Trial of Cablivi (caplacizumab) for Rare Blood Clotting Disorder

PARIS, Jan. 9, 2019 /PRNewswire/ — The New England Journal of Medicine (NEJM) today published ...
read more